6ML vs NVS: Side-by-Side Comparison
Compare MOLECULAR PARTNERS SF 1 (6ML) and Novartis AG (NVS) side by side: market cap EUR 126.79M vs USD 305.10B. Financials, growth and model signals on Bullrun.
| Metric | 6ML | NVS |
|---|---|---|
| Company | MOLECULAR PARTNERS SF 1 | Novartis AG |
| Country / Exchange | Switzerland · F | Switzerland · NYSE |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Drug Manufacturers-General |
| Market cap | EUR 126.79M | USD 305.10B |
| P/E ratio | — | 22.8 |
| Dividend yield | — | 2.98% |
| Valuation model | — | 8.9% undervalued |
| Revenue (latest FY) | — | — |
| Revenue growth YoY | — | — |
| Net income | — | — |
| Gross margin | — | — |
| Diluted EPS | — | — |